Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 1;8(11):14214-20.
eCollection 2015.

Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro

Xuhui Lei  1 , Liang Chang  2 , Wei Ye  1 , Chuanlu Jiang  1 , Zhiren Zhang  3
Affiliations

Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro

Xuhui Lei et al. Int J Clin Exp Pathol. .

Abstract

Objective: To investigate the effects and the potential mechanisms of RKIP on cell migration, invasion and proliferation in human glioma cell lines in vitro.

Methods: The RKIP over-expressing and RKIP knockdown human U87 glioma cells were used to reveal the effects of RKIP on human glioma cells migration, invasion and proliferation. After the recombinant plasmid pcDNA3.0-RKIP or RKIP-shRNA was transfected into the cell lines U87 by the means of liposome assay, the cells migration, invasion and proliferation were detected by wound healing, Transwell and MTT assay. Then, the levels of RKIP, MMP-3, MMP-9 and HMGA2 mRNA transcription were measured by means of RT-qPCR and levels of proteins expressions were determined using Western blot.

Results: The results of MTT assay suggested that the PKIP have little inhibitive effects on glioma cells proliferation (P>0.05). The present paper showed that the migration distances in the group of RKIP-shRNA were markedly increased compared to the pcDNA3.0-RKIP and control. Similarly, the results showed that the numbers of invasion cells in RKIP-shRNA were remarkably increased than the pcDNA3.0-RKIP group and control group. Western blot and RT-qPCR suggested that over-expressions of RKIP lessened the MMP-2, MMP-9 and HMGA2 expression, however, turning down the RKIP expression showed the inverse effects.

Conclusion: RKIP inhibits the cells migrations and invasions. Meanwhile, RKIP might inhibit the glioma cells through inhibiting MMPs and HMAG2 expression. Therefore, we demonstrated that RKIP is an underlying target for the treatment of glioma.

Keywords: HMGA2; Raf kinase inhibitor protein (RKIP); glioma; invasion; migration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of RKIP on cells migration in human U87 glioma cell by means of wound healing assay. The relative distance was ratio of experimental group distance vs. the distance of the cell-blank scratch at 12 h, 14 h and 48 h after transfection. *P<0.05, **P<0.01.
Figure 2
Figure 2
Effects of RKIP on cells invasion in human U87 glioma cell by means of Transwell assay. The number of glioma cells cross through the membrane was recorded. *P<0.05, **P<0.01.
Figure 3
Figure 3
The effects of RKIP on the proliferation of U87 glioma cells. To determine the effects of RKIP on the ability of proliferation in U87 cells, the MTT assays were carried out to detected the proliferations of cells that over-expressing or down regulating of RKIP. The results showed that RKIP had little effects on the proliferation of U87 glioma cells.
Figure 4
Figure 4
Effects of over-expressing and knockdown RKIP on mRNA expressions in human U87 glioma cells. A. The RKIP mRNA relative expressions (vs. GAPDH), B. The MMP-2 mRNA relative expression (vs. GAPDH), C. The MMP-9 mRNA relative expressions (vs. GAPDH), D. The HMGA2 mRNA relative expression (vs. GAPDH), *P<0.05, **P<0.01.
Figure 5
Figure 5
Effects of over-expressing and knockdown RKIP on protein expression in human U87 glioma cells. A. The RKIP protein relative expressions (vs. GAPDH), B. The protein relative expression of MMP-2, MMP-9 and HMGA2, *P<0.05, **P<0.01.
See this image and copyright information in PMC

References

    1. Abrams DA, Hanson JA, Brown JM, Hsu FP, Delashaw JB Jr, Bota DA. Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma. J Clin Neurosci. 2015;22:35–39. - PubMed
    1. Afshordel S, Kern B, Clasohm J, Konig H, Priester M, Weissenberger J, Kogel D, Eckert GP. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation. Pharmacol Res. 2015;91:69–77. - PubMed
    1. Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res. 2014;6:149–170. - PMC - PubMed
    1. Yang L, Gao S, Asghar S, Liu G, Song J, Wang X, Ping Q, Zhang C, Xiao Y. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int J Biol Macromol. 2015;72:1391–1401. - PubMed
    1. Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC, Keller ET. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer. Prostate. 2015;75:292–302. - PubMed

Publication types

MeSH terms